Alnylam Pharmaceuticals Inc (ALNY) Stock Price, Quote, News & History

ALNYNASDAQ
$278.09
-4.63-1.64%
At close: Jun 18, 5:00 PM EST
$277.94
-0.15-0.05%
After Hours: Jun 18, 5:00 PM EST
60%

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change

Cash Flows

Operating Cash Flow (TTM)
714.90M
Investing Cash Flow (TTM)
297.02M
Financing Cash Flow (TTM)
-335.56M
Free Cash Flow (TTM)
643.34M
Capital Expenditure (TTM)
-71.56M
Net Change in Cash (TTM)
676.36M

Analyst Trends and Forecast

2
Mar
1
Apr
3
1
May
1
Jun
Buy
Hold
Sell
Strong Sell

Analyst Rating and Forecast

12345
3.5
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Valuation Metrics

Enterprise Value
$35.39B
PE Ratio (TTM)
71.04
PE Ratio (FWD)
30.30
PEG Ratio (TTM)
0.48
PS Ratio (TTM)
9.02
PB Ratio (TTM)
35.10
Earnings Yield % (TTM)
1.41%
Earnings Yield % (FWD)
3.30%
EV / EBITDA (TTM)
41.60
Price / EBITDA (TTM)
44.69
Price / Free Cash Flow (TTM)
60.13
Book Value / Share
$8.05

Company Debt

Total Debt
$1.01B
LT Debt
$1.01B
LT Debt Issuance (TTM)
-
LT Debt Repayment (TTM)
-
Total Cash
$1.71B
Debt to Equity
1.18
Issuance of Debt (TTM)
-
Repayment of Debt (TTM)
-

Key Statistics

Open
$280.11
Close
$278.09
Volume / Avg.
2.20M / 1.12M
Day Range
$273.11 - $282.98
52 Wk Range
276.94 - 495.55
Market Cap
$37.09B
P/E Ratio
71.04
Dividend Yield
-
Exchange
NASDAQ
RSI
39
Short Interest
5.3%
Days to Cover
5.78

About

Sector
Health Care
Industry
Biotechnology
Alnylam Pharmaceuticals is a leader in the study of RNA interference (RNAi) therapeutics. RNAi is a naturally occurring biological pathway within cells for sequence-specific silencing and regulation of gene expression. Alnylam's commercial RNAi thera...
Show More
Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS better than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

FAQ

Q

How do I buy Alnylam Pharmaceuticals (ALNY) stock?

A

You can purchase shares of Alnylam Pharmaceuticals (NASDAQ:ALNY) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Alnylam Pharmaceuticals (ALNY) competitors?

A

There are no as such competitors for Alnylam Pharmaceuticals.

Q

What is the forecast, or price target, for Alnylam Pharmaceuticals (ALNY) stock?

A

Alnylam Pharmaceuticals has a consensus price target of $461.00.

Q

What is the current price for Alnylam Pharmaceuticals (ALNY)?

A

The stock price for Alnylam Pharmaceuticals (NASDAQ: ALNY) is $277.94 last updated June 18, 2026 at 5:00 PM EDT.

Q

Does Alnylam Pharmaceuticals (ALNY) pay a dividend?

A

There are no upcoming dividends for Alnylam Pharmaceuticals.

Q

When is Alnylam Pharmaceuticals (NASDAQ:ALNY) reporting earnings?

A

Alnylam Pharmaceuticals does not have any upcoming earnings scheduled.

Q

Is Alnylam Pharmaceuticals (ALNY) going to split?

A

There is no upcoming split for Alnylam Pharmaceuticals.

Q

What sector and industry does Alnylam Pharmaceuticals (ALNY) operate in?

A

Alnylam Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.